Indeed, phospho‐ERK signals display significant heterogeneity within tumours (Houben et al., 2008), and considering phospho‐ERK levels when assessing BRN2 and MITF expression levels could help to shed more light on their regulation in melanoma. The gene discussed is MAPK1; the disease is melanoma.